Ads
related to: abbv stock dividend history data
Search results
Results From The WOW.Com Content Network
Pharmaceutical powerhouse AbbVie (NYSE: ABBV) has been a beast since it spun off from Abbott Laboratories in 2012. Over the past decade, the stock has averaged a dividend yield of 3.5% while ...
In June, Abbvie acquired TeneoOne and its lead compound TNB-383B. The compound is a BCMA-targeting immunotherapeutic for relapsed or refractory multiple myeloma. [30] In March 2022, AbbVie acquired Syndesi Therapeutics for up to $1 billion and its portfolio of novel modulators of the synaptic vesicle protein 2A and lead compound SDI-118.
ABBV Total Return Level data by YCharts. The lesson: AbbVie's business is strong. The company's dividend program makes the stock that much more attractive and capable of delivering superior ...
ABBV Dividend Growth (Annual) data by YCharts. Despite the slowdown, AbbVie's current dividend yield of 3.19% remains attractive. This yield slightly exceeds the average of 3.12% among its big ...
The S&P 500 Dividend Aristocrats is a stock market index composed of the companies in the S&P 500 index that have increased their dividends in each of the past 25 consecutive years. It was launched in May 2005.
Let's consider two excellent options: AbbVie (NYSE: ABBV) and Amgen (NASDAQ: AMGN). 1. AbbVie. AbbVie continues to recover from one of the biggest patent cliffs in the pharmaceutical industry's ...